So you’re advocating for production of 17,179,869,183 variants of the vaccine in order to achieve personalized? Or for sanity sake in production do you think they’ll minimize it down to a manageable amount of variants? Which hopefully achieve efficacy with a manageable toolbox of vaccines.
They will make a specific vaccine for a specific individual on demand. Just like NWBO would do if approved.
Think of 34 antigens feeding the process. Each is either mixed in or not depended on the patient.